Atlas Trials

Addition of Vismodegib to Neoadjuvant Chemotherapy in Triple Negative Breast Cancer Patients

Clinical trial NCT02694224 · UNKNOWN

Trial details

NCT number
NCT02694224
Sponsor
Clinica Universidad de Navarra, Universidad de Navarra
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Breast Cancer
Start date
2016-04-01
Primary completion
2017-12-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.